Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 5, 2006, Pages 553-557

  Goktas, E O ^a   Aydin, F ^a   Senturk, N ^a   Canturk, M T ^a   Turanli, A Y ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Narrow band UVB and topical calcipotriol; Phototherapy; Treatment; Vitiligo

Indexed keywords

CALCIPOTRIOL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; PRURITUS; RADIATION DOSE; RADIATION EXPOSURE; SKIN PIGMENTATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION; VITILIGO; XEROSIS;

ADOLESCENT; ADULT; CALCITRIOL; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 33646050911     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01546.x     Document Type: Article

References (17)

1. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 647-666.
2. Shaffrali FCG, Gawkrodger DJ. Management of vitiligo. Clin Exp Dermatol 2000; 25: 575-579.
3. Dogra S, Parsad D. Combination of narrowband UVB and topical calcipotriene in vitiligo. Arch Dermatol 2003; 139: 393.
4. Köse O, Gür AR, Kurumlu Z et al. Calcipotriol ointment versus clobetasol ointment in localized vitiligo: An open, comparative clinical trial. Int J Dermatol 2002; 41: 616.
5. Yashar SS, Gielczyk R, Scherschun L et al. Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Photoderm Photoimmunol Photomed 2003; 19: 164-168.
6. Jimbow K. Vitiligo therapeutic advances. Dermatol Clin 1998; 16: 399-407.
7. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
8. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs. topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-1528.
9. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998; 197: 167-170.
10. Yalçin B, Şahin S, Bükülmez G et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: A preliminary study. J Am Acad Dermatol 2001; 44: 634-637.
11. Ermis O, Alpsoy E, Çetin L et al. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 2001; 145: 472-475.
12. Ameen M, Exarchou V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 2001; 145: 476-479.
13. Bagot M, Charue D, Lescs MC et al. Immunosuppressive effects of 1,25 dihydroxyvitamin D3 and its analogue calcipotriol on epidermal cells. Br J Dermatol 1994; 130: 424-431.
14. Kragballe K. The future of vitamin D in dermatology. J Am Acad Dermatol 1997; 37: 72-76.
15. Chiaverini C, Passeron T, Ortonne JP. Treatment of vitiligo by topical calcipotriol. J Eur Acad Dermatol Venereol 2002; 16: 137-138.
16. Baysal V, Yildirim M, Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo. J Eur Acad Dermatol Venereol 2003; 17: 299-302.
17. Hartmann A, Lurz C, Hamm H et al. Narrow-band UVB311 nm vs. Broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Int J Dermatol 2005; 44: 736-742